同期放化疗作为原发性中枢神经系统神经母细胞瘤的辅助治疗。
Concurrent Chemoradiotherapy as an Adjuvant Treatment of Primary Central Nervous System Neuroblastoma.
机构信息
University of Tunis El Manar, Faculty of Medicine of Tunis, Ariana, Tunisia.
Department of Radiation Oncology, Abderrahmen Mami Hospital, Ariana, Tunisia.
出版信息
Perm J. 2022 Jun 29;26(2):166-171. doi: 10.7812/TPP/21.147. Epub 2022 Jun 17.
Abstract
Primary central nervous system neuroblastoma is a rare malignant embryonal tumor. With only few cases reported in the literature, data on regardingthe diagnosis and management of these tumors are limited. We reported a case of primary cerebral neuroblastoma in a 20-year-old woman complaining of progressive headaches. The patient underwent subtotal tumor resection and adjuvant concurrent chemoradiotherapy. The prescription dose was 54 Gy. She remained free of recurrence for 14 months after the end of radiotherapy treatment.
摘要
原发性中枢神经系统神经母细胞瘤是一种罕见的恶性胚胎瘤。由于文献中仅报道了少数病例，因此关于这些肿瘤的诊断和治疗的数据有限。我们报告了一例 20 岁女性原发性脑神经母细胞瘤病例，该患者主诉进行性头痛。患者接受了肿瘤次全切除术和辅助同步放化疗。处方剂量为 54Gy。放疗结束后 14 个月，患者无复发。
相似文献
1
Concurrent Chemoradiotherapy as an Adjuvant Treatment of Primary Central Nervous System Neuroblastoma.同期放化疗作为原发性中枢神经系统神经母细胞瘤的辅助治疗。
Perm J. 2022 Jun 29;26(2):166-171. doi: 10.7812/TPP/21.147. Epub 2022 Jun 17.
2
Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent Children's Cancer Group studies.巩固性放化疗及自体骨髓移植与继续化疗治疗转移性神经母细胞瘤的比较：儿童癌症研究组两项同期研究报告
J Clin Oncol. 1996 Sep;14(9):2417-26. doi: 10.1200/JCO.1996.14.9.2417.
3
A phase-II/III randomized controlled trial of adjuvant radiotherapy or concurrent chemoradiotherapy after surgery versus surgery alone in patients with stage-IIB/III esophageal squamous cell carcinoma.一项 II/III 期随机对照临床试验，比较了手术后辅助放疗或同期放化疗与单纯手术治疗 IIB/III 期食管鳞癌患者的效果。
BMC Cancer. 2020 Feb 18;20(1):130. doi: 10.1186/s12885-020-6592-2.
4
[A case of malignant peritoneal mesothelioma successfully treated with concurrent chemoradiotherapy].[1例恶性腹膜间皮瘤同步放化疗成功治疗的病例]
Gan To Kagaku Ryoho. 2011 Dec;38(13):2639-41.
5
[Comprehensive treatment of neuroblastoma in children associated with opsoclonus-myoclonus-ataxia syndrome].[儿童神经母细胞瘤合并眼阵挛-肌阵挛-共济失调综合征的综合治疗]
Zhonghua Er Ke Za Zhi. 2014 Jul;52(7):540-3.
6
Surgical treatment versus concurrent chemoradiotherapy as an initial treatment modality in advanced olfactory neuroblastoma.手术治疗与同步放化疗作为晚期嗅神经母细胞瘤的初始治疗方式比较
Auris Nasus Larynx. 2007 Dec;34(4):493-8. doi: 10.1016/j.anl.2007.02.005. Epub 2007 May 11.
7
Primary tumor control in patients with stage 3/4 unfavorable neuroblastoma treated with tandem double autologous stem cell transplants.接受串联双自体干细胞移植治疗的3/4期高危神经母细胞瘤患者的原发肿瘤控制情况
J Pediatr Hematol Oncol. 2003 Dec;25(12):934-40. doi: 10.1097/00043426-200312000-00005.
8
Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial.同期放化疗加辅助化疗与单纯同期放化疗治疗局部晚期鼻咽癌患者的随机对照 3 期多中心临床试验。
Lancet Oncol. 2012 Feb;13(2):163-71. doi: 10.1016/S1470-2045(11)70320-5. Epub 2011 Dec 7.
9
Primary cerebral neuroblastoma: a case treated with adjuvant chemotherapy and radiotherapy.原发性脑成神经细胞瘤：1例辅助化疗和放疗治疗病例
Turk J Pediatr. 2004 Apr-Jun;46(2):182-5.
10
[A Patient with Primary Intraventricular Gliosarcoma and Long-term Survival - a Case Report].[一例原发性脑室内胶质肉瘤患者及长期生存——病例报告]
Klin Onkol. 2016 Winter;29(6):454-459. doi: 10.14735/amko2016454.
本文引用的文献
1
Incidence, Treatment, and Survival in Primary Central Nervous System Neuroblastoma.原发性中枢神经系统神经母细胞瘤的发病率、治疗及生存情况
World Neurosurg. 2020 Aug;140:e61-e72. doi: 10.1016/j.wneu.2020.04.145. Epub 2020 Apr 25.
2
Central nervous system (CNS) neuroblastoma. A case-based update.中枢神经系统（CNS）神经母细胞瘤。基于病例的最新进展。
Childs Nerv Syst. 2018 May;34(5):817-823. doi: 10.1007/s00381-018-3764-3. Epub 2018 Mar 8.
3
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.2016 年世界卫生组织中枢神经系统肿瘤分类：概述。
Acta Neuropathol. 2016 Jun;131(6):803-20. doi: 10.1007/s00401-016-1545-1. Epub 2016 May 9.
4
Radiation therapy to the primary and postinduction chemotherapy MIBG-avid sites in high-risk neuroblastoma.对高危神经母细胞瘤的原发灶及诱导化疗后间碘苄胍（MIBG）摄取阳性部位进行放射治疗。
Int J Radiat Oncol Biol Phys. 2014 Nov 15;90(4):858-62. doi: 10.1016/j.ijrobp.2014.07.019. Epub 2014 Sep 20.
5
Clinical, biologic, and prognostic differences on the basis of primary tumor site in neuroblastoma: a report from the international neuroblastoma risk group project.神经母细胞瘤中原发肿瘤部位的临床、生物学及预后差异：国际神经母细胞瘤风险组项目报告
J Clin Oncol. 2014 Oct 1;32(28):3169-76. doi: 10.1200/JCO.2014.56.1621. Epub 2014 Aug 25.
6
Neurocognitive function after radiotherapy for paediatric brain tumours.儿童脑瘤放疗后的神经认知功能。
Nat Rev Neurol. 2012 Oct;8(10):578-88. doi: 10.1038/nrneurol.2012.182. Epub 2012 Sep 11.
7
Hyperfractionated versus conventional radiotherapy followed by chemotherapy in standard-risk medulloblastoma: results from the randomized multicenter HIT-SIOP PNET 4 trial.超分割放疗联合常规放化疗对比常规放化疗治疗标准风险髓母细胞瘤：来自随机多中心 HIT-SIOP PNET 4 试验的结果。
J Clin Oncol. 2012 Sep 10;30(26):3187-93. doi: 10.1200/JCO.2011.39.8719. Epub 2012 Jul 30.
8
The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report.国际神经母细胞瘤风险组（INRG）分类系统：INRG 工作组报告。
J Clin Oncol. 2009 Jan 10;27(2):289-97. doi: 10.1200/JCO.2008.16.6785. Epub 2008 Dec 1.
9
Cerebral radiation necrosis: incidence, outcomes, and risk factors with emphasis on radiation parameters and chemotherapy.脑放射性坏死：发病率、结局及危险因素，重点关注放射参数和化疗
Int J Radiat Oncol Biol Phys. 2006 Jun 1;65(2):499-508. doi: 10.1016/j.ijrobp.2005.12.002. Epub 2006 Mar 6.
10
Primary cerebral neuroblastoma: a case treated with adjuvant chemotherapy and radiotherapy.原发性脑成神经细胞瘤：1例辅助化疗和放疗治疗病例
Turk J Pediatr. 2004 Apr-Jun;46(2):182-5.
Zotero 插件